We are live on
!
Find out more
Corcept Therapeutics
CORT
CORT
183 hedge funds and large institutions have $962M invested in Corcept Therapeutics in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 65 increasing their positions, 64 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
59% more call options, than puts
Call options by funds: $5.21M | Put options by funds: $3.27M
2% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 64
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.12% less ownership
Funds ownership: 76.24% → 75.12% (-1.1%)
6% less capital invested
Capital invested by funds: $1.03B → $962M (-$65.1M)
12% less funds holding
Funds holding: 208 → 183 (-25)
53% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 38
Holders
183
Holders Change
-25
Holders Change %
-12.02%
% of All Funds
3.97%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
18
Increased
65
Reduced
64
Closed
38
Calls
$5.21M
Puts
$3.27M
Net Calls
+$1.94M
Net Calls Change
+$5.18M
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$9.57M |
| 2 |
Morgan Stanley
New York
|
+$6.17M |
| 3 |
Renaissance Technologies
New York
|
+$5.94M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$5.83M |
| 5 |
MCM
Matarin Capital Management
New York
|
+$5.2M |
Top Sellers
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$10.1M |
| 2 |
CCM
Consonance Capital Management
New York
|
-$9.63M |
| 3 |
Millennium Management
New York
|
-$4.73M |
| 4 |
Goldman Sachs
New York
|
-$3.74M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$3.69M |
